Protocols are getting more complex - we know this. As therapies become more targeted, biomarkers more sophisticated, and data expectations more expansive, it is easy to assume that increasing complexity is simply the cost of scientific progress.

But operational complexity is different from scientific complexity.

Across clinical development, sponsors continue to invest in technology, AI, decentralized models, and operational innovation to accelerate study execution. Yet many of those gains are constrained by protocols that require increasingly intensive site resources, longer startup timelines, greater patient burden, and more operational coordination than studies can realistically support.

The question is no longer whether protocols have become more complex. It is whether all of that complexity creates value.

Every Additional Requirement Carries an Operational Cost

Protocol design is often viewed as a scientific exercise. In practice, every operational decision made during protocol development echoes throughout the rest of the study.

An additional endpoint may require new procedures. Another laboratory assessment adds specimen handling requirements. Expanded eligibility criteria create additional screening work. More frequent visits increase scheduling complexity for both patients and sites.

Each individual decision may appear reasonable in isolation. Collectively, they shape how difficult a study becomes to execute. Operational burden is rarely created by one major design choice. It is usually the accumulation of many small ones.

More Data Does Not Always Mean Better Decisions

Clinical trials naturally seek to reduce uncertainty. One common response is to collect more information. Additional exploratory endpoints, supplementary assessments, and "nice-to-have" data often find their way into protocols because they may prove useful later.

Sometimes they do. Often they do not.

Every additional data point carries downstream consequences for investigators, coordinators, monitors, patients, laboratories, and data management teams. The most scalable studies are not those that collect the most information. They are those that collect the information that matters most.

Simplicity Creates Capacity

Protocol simplification is sometimes misunderstood as compromise. In reality, simplicity often expands operational capacity.

Sites managing dozens of concurrent studies can focus more effectively on participants when visit schedules are realistic and procedures are purposeful. Startup teams spend less time configuring systems when workflows are streamlined. Patients are more likely to remain engaged when participation fits more naturally into everyday life.

The result is greater resilience.

Simpler studies are often easier to launch, easier to manage, and easier to scale across diverse research environments.

Designing With Execution in Mind

One of the most important shifts occurring in protocol development is the growing involvement of operational stakeholders earlier in the design process.

Clinical operations, site representatives, feasibility specialists, data management teams, patient engagement leaders, and technology partners all bring perspectives that complement scientific objectives.

These conversations often reveal questions that would otherwise emerge much later.

• Can community sites realistically perform these assessments?
• Does the visit schedule align with routine clinical practice?
• Will patients be willing to complete these procedures over the full study duration?
• How much additional work does each new requirement create?

When operational realities influence protocol decisions early, studies become easier to execute without sacrificing scientific integrity.

Scalability Starts Before Startup

Study startup is often where complexity first becomes visible. Systems must be configured. Sites must be trained. Vendors interpret protocol language independently. Budgets expand as operational requirements increase.

By this point, however, the protocol has already established much of the work that follows. This is why startup teams frequently find themselves managing complexity rather than preventing it.

Scalable execution begins much earlier. It begins when protocols are designed with implementation in mind.

Simplicity Supports Better Technology

Technology performs best when workflows are clear.

Machine-readable protocols, AI-assisted startup, automated database configuration, operational simulations, and workflow orchestration all depend on structured, consistent processes. Highly variable, unnecessarily complex protocols reduce the effectiveness of these capabilities. Simplification therefore creates a multiplier effect.

Organizations gain more value from technology because technology spends less effort compensating for avoidable operational variation.

A Different Way to Think About Protocol Design

Protocol simplicity should be viewed as a way to strengthen execution without weakening the science.

The most effective protocols are not defined by how many procedures they include or how much data they collect. They are defined by how clearly every requirement contributes to the study's objectives while remaining practical for sites and participants to execute consistently.

That requires discipline during protocol development. Every assessment should answer an important scientific question. Every data element should have a clear purpose. Every operational requirement should be weighed against the time, effort, and complexity it introduces across the study.

When protocol teams make those trade-offs deliberately, studies become easier to scale across different sites, healthcare settings, and patient populations. Operational efficiency is no longer something pursued during startup or study conduct. It becomes a characteristic of the protocol itself, creating stronger alignment between scientific ambition and successful execution.

Continue the Conversation at SCOPE Summit Europe

Protocol design, operational excellence, and study startup continue to evolve as organizations look for new ways to improve trial execution without compromising scientific rigor.

Registration is now open for SCOPE Summit Europe where sponsors, CROs, research sites, and technology leaders will explore practical strategies for designing more efficient, patient-centered clinical trials.

Learn more and register here.